Skip to main content

Celldex Therapeutics, Inc.

CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000744218

No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Celldex Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
229
+45 vs. Q4 2025
Shares held
72.6M
+3.57M (+5.2%) vs. Q4 2025
Total value
$2.31B
+$428.6M (+22.7%) vs. Q4 2025
New holders
59
68 more added
Sold out
14
58 more reduced

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CLDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 229 institutions
Q1 2021: 115 institutionsQ2 2021: 132 institutionsQ3 2021: 161 institutionsQ4 2021: 181 institutionsQ1 2022: 169 institutionsQ2 2022: 158 institutionsQ3 2022: 160 institutionsQ4 2022: 168 institutionsQ1 2023: 161 institutionsQ2 2023: 150 institutionsQ3 2023: 144 institutionsQ4 2023: 164 institutionsQ1 2024: 197 institutionsQ2 2024: 183 institutionsQ3 2024: 176 institutionsQ4 2024: 174 institutionsQ1 2025: 171 institutionsQ2 2025: 182 institutionsQ3 2025: 184 institutionsQ4 2025: 187 institutionsQ1 2026: 229 institutionsQ2 2026: 253 institutions
Value heldQ1 2026: $2.31B
Q1 2021: $709.5MQ2 2021: $1.19BQ3 2021: $2.33BQ4 2021: $1.79BQ1 2022: $1.69BQ2 2022: $1.30BQ3 2022: $1.39BQ4 2022: $2.17BQ1 2023: $1.78BQ2 2023: $1.70BQ3 2023: $1.39BQ4 2023: $2.42BQ1 2024: $2.91BQ2 2024: $2.58BQ3 2024: $2.44BQ4 2024: $1.86BQ1 2025: $1.34BQ2 2025: $1.48BQ3 2025: $1.83BQ4 2025: $1.99BQ1 2026: $2.31BQ2 2026: $3.16B
Institutions holding CLDX and their total value by quarter
QuarterHoldersValue
Q2 2026253$3.16B
Q1 2026229$2.31B
Q4 2025187$1.99B
Q3 2025184$1.83B
Q2 2025182$1.48B
Q1 2025171$1.34B
Q4 2024174$1.86B
Q3 2024176$2.44B
Q2 2024183$2.58B
Q1 2024197$2.91B
Q4 2023164$2.42B
Q3 2023144$1.39B
Q2 2023150$1.70B
Q1 2023161$1.78B
Q4 2022168$2.17B
Q3 2022160$1.39B
Q2 2022158$1.30B
Q1 2022169$1.69B
Q4 2021181$1.79B
Q3 2021161$2.33B
Q2 2021132$1.19B
Q1 2021115$709.5M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Celldex Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding CLDX in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Northern Trust Corp577,267$18.3M0.00%+27,269+5.0%Added
Vanguard Portfolio Management LLC629,252$20.0M0.00%+629,252New
Rock Springs Capital Management LP650,270$20.6M1.22%−42,268−6.1%Reduced
Baker Bros. Advisors LP665,370$21.1M0.12%00.0%Unchanged
Bank of America Corp708,647$22.5M0.00%+293,759+70.8%Added
American Century Companies Inc856,310$27.2M0.01%+1,084+0.1%Added
Elmind Capital, LP865,000$27.4M7.79%00.0%Unchanged
Pictet Asset Management Holding SA923,696$29.3M0.03%−44,920−4.6%Reduced
Goldman Sachs Group Inc988,416$31.4M0.00%−79,715−7.5%Reduced
Fisher Asset Management, LLC1,013,648$32.2M0.01%+76,490+8.2%Added
Eventide Asset Management, LLC1,037,000$32.9M0.54%−605,559−36.9%Reduced
Dimensional Fund Advisors LP1,059,534$33.6M0.01%+407,818+62.6%Added
Bellevue Group AG1,200,000$38.1M0.91%−2,417,669−66.8%Reduced
Novo Holdings A/S1,200,000$38.1M3.08%00.0%Unchanged
Vestal Point Capital, LP1,224,165$38.8M1.09%+59,165+5.1%Added
Millennium Management LLC1,253,532$39.8M0.03%+40,827+3.4%Added
Deep Track Capital, LP1,283,979$40.7M0.84%−616,759−32.4%Reduced
Braidwell LP1,356,082$43.0M1.43%−502,027−27.0%Reduced
Geode Capital Management, LLC1,688,074$53.6M0.00%+60,545+3.7%Added
Eversept Partners, LP1,788,016$56.7M3.74%+353,291+24.6%Added
Price T Rowe Associates Inc2,086,332$66.2M0.01%+46,627+2.3%Added
Commodore Capital LP2,696,616$85.5M4.95%+131,616+5.1%Added
State Street Corp2,804,168$88.9M0.00%−593,545−17.5%Reduced
Vanguard Capital Management LLC2,960,895$93.9M0.00%+2,960,895New
Point72 Asset Management, L.P.3,229,939$102.5M0.18%+1,471,582+83.7%Added
FMR LLC3,749,048$118.9M0.01%−1,158,421−23.6%Reduced
BlackRock, Inc.5,369,885$170.3M0.00%−81,930−1.5%Reduced
Kynam Capital Management, LP5,840,567$185.3M11.76%−102,613−1.7%Reduced
Wellington Management Group LLP8,560,476$271.5M0.05%+480,868+6.0%Added
Polar Capital Holdings Plc0$00.00%−1,008,163−100.0%Sold out
Renaissance Technologies LLC0$00.00%−118,488−100.0%Sold out
Argent Trust Co0$00.00%−8,481−100.0%Sold out
Quest Partners LLC0$00.00%−8,018−100.0%Sold out
Values First Advisors, Inc.0$00.00%−7,728−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−3,600−100.0%Sold out
Amalgamated Bank0$00.00%−2,058−100.0%Sold out
Group One Trading, L.P.0$00.00%−748−100.0%Sold out
Clear Street Markets LLC0$00.00%−452−100.0%Sold out
Quarry LP0$00.00%−180−100.0%Sold out
Strategic Advocates LLC0$00.00%−130−100.0%Sold out
Bare Financial Services, Inc0$00.00%−79−100.0%Sold out
Concord Wealth Partners0$00.00%−8−100.0%Sold out
Strategic Investment Solutions, Inc.0$00.00%−5−100.0%Sold out
Vanguard Group Inc––––Not filed
CIBC Private Wealth Group, LLC––––Not filed
Comerica Bank––––Not filed